The study consisted of a single-blinded randomized, controlled clinical trial with treatment and control groups running in parallel for a period of 8 wk. Ethical Committee of Tabriz University of Medical Sciences approved the study protocol, and was registered on the Iranian Registry of Clinical Trials website. The study was conducted in accordance with the guidelines of the Declaration of Helsinki principles. All subjects gave written informed consent before clinical trial enrolment.